NCSM News and Press, NCS Multistage Holdings Inc. From 05/01/24

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

HOUSTON, April 23, 2024 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) will host a conference call to discuss its first quarter 2024 results on Thursday, May 2, 2024 at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). NCS will ...

2024-04-17 04:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Dallas, Texas--(Newsfile Corp. - March 12, 2024) - NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). To view the full announcement, including downloadable images, bios, and more, click here . Ke...

2024-03-08 11:01:10 ET NCS Multistage Holdings, Inc. (NCSM) Q4 2023 Earnings Conference Call March, 08, 2024 08:30 AM ET Company Participants Mike Morrison - Chief Financial Officer Ryan Hummer - Chief Executive Officer Conference Call Participants Dave S...

2024-03-07 17:25:59 ET More on NCS Multistage Holdings Historical earnings data for NCS Multistage Holdings Financial information for NCS Multistage Holdings Read the full article on Seeking Alpha For further details see: NCS Multistage Holdings Non-GAAP ...

Fourth Quarter Results Total revenues of $35.2 million, compared to $40.2 million in 2022 Net income of $39.6 million and earnings per diluted share of $15.80, benefited by a legal settlement, compared to $2.0 million and earnings per diluted share of $0.81 for the fourth quarter of 2...

Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...

Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...

HOUSTON, March 01, 2024 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) will host a conference call to discuss its fourth quarter and full year 2023 results on Friday, March 8, 2024 at 7:30 a.m. Central Time (8:30 a.m. Eastern T...